| Vol. 6.41 – 18 November, 2022 |
| |
|
|
| Modest overexpression of SIRT4 protected the liver from fibrosis by inhibiting the transformation of glutamate to 2-ketoglutaric acid in the tricarboxylic acid cycle, thereby reducing the proliferative activity of hepatic stellate cells. [Cell Death & Disease] |
| |
|
|
PUBLICATIONSRanked by the impact factor of the journal |
|
|
|
| Cell-based experiments showed that elevated levels of GALNT14 promoted HCC growth, migration, and resistance to anticancer drugs. [Cell Death & Disease] |
|
|
|
| Researchers investigated the interplay among neuropilin-1, autophagy, and hypoxia in the development of lenvatinib resistance in HCC cell lines. [Acta Pharmacologica Sinica] |
|
|
|
| Human liver samples, Bgn–/0 mice and a human LX-2 hepatic stellate cells model were applied for the study of experimental fibrosis. [Liver International] |
|
|
|
| Scientists examined the potential role of SGOL2 in cancers, especially in HCC. Immunohistochemistry, immunofluorescence, western blot, o-immunoprecipitation technique, and bioinformatic analysis were utilized to assess the role of SGOL2 in HCC development process. [Biomarker Research] |
|
|
|
| In vitro and in vivo gain- and loss-of-function experiments showed that LINC01468 promoted the proliferation of HCC cells through lipogenesis. [Cell Death Discovery] |
|
|
|
| Investigators performed RNA sequencing of liver biopsies from ten HCC, ten hepatitis C virus-associated HCC, and four normal livers to identify dysregulated lncRNAs in HCC. [Scientific Reports] |
|
|
|
| To clarify the effects and mechanisms of gemigliptin, the authors conducted various experiments in LX-2 cells, which were activated by succinate and exhibited elevated expression of α-smooth muscle actin, collagen type 1, and pro-inflammatory cytokines and increased cell proliferation. [Endocrinology and Metabolism] |
|
|
|
| Among a series of novel small-molecule compounds, a potential anti-fibrosis drug compd.1 was founded to be able to dose-dependently down-regulate ACTA2 and CTGF mRNA levels in human hepatic stellate cells treated with TGF-β. [Bioorganic & Medicinal Chemistry] |
| |
|
|
|
| Investigators summarize the latest clinical advances in the treatment of advanced HCC and discuss future perspectives that might inform the development of more effective therapeutics for advanced HCC. [Nature Reviews Gastroenterology & Hepatology] |
|
|
|
| The authors review the mechanisms of hepatic regeneration and their potential to influence HCC development. [Trends in Cancer] |
|
|
|
| Scientists highlight the importance of protein phosphatases in HCC development and in the regulation of the cellular components in the liver microenvironment and to show their significance as therapeutic targets. [Experimental and Molecular Medicine] |
|
|
|
|
| Escient Pharmaceuticals announced the initiation of a Phase II clinical study of EP547 in subjects with cholestatic pruritus. EP547 is a highly selective antagonist of MRGPRX4, a cell surface receptor expressed on sensory neurons that is activated by bile acids, bilirubin and other heme metabolite. [Escient Pharmaceuticals] |
|
|
|
| The Hepatitis B Foundation, a global nonprofit organization, today announced that Stephan Urban, PhD, distinguished professor and globally recognized virologist, has been chosen to receive its 2023 Baruch S. Blumberg Prize. [Hepatitis B Foundation] |
|
|
|
|
| February 5 – 8, 2023 Keystone, Colorado, United States |
|
|
|
|
|
| STEMCELL Technologies, Inc. – Boston, Massachusetts, United States |
|
|
|
| University of Bristol – Bristol, United Kingdom |
|
|
|
| Imperial College London – London, England, United Kingdom |
|
|
|
| Helmholtz Munich – Neuherberg, Germany |
|
|
|
| Novo Nordisk – Seattle, Washington, United States |
|
|
|
|